It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
The RNA world is changing our views about sensing and resolution of DNA damage. Here, we develop single-molecule DNA/RNA analysis approaches to visualize how nascent RNA facilitates the repair of DNA double-strand breaks (DSBs). RNA polymerase II (RNAPII) is crucial for DSB resolution in human cells. DSB-flanking, RNAPII-generated nascent RNA forms RNA:DNA hybrids, guiding the upstream DNA repair steps towards favouring the error-free Homologous Recombination (HR) pathway over Non-Homologous End Joining. Specific RNAPII inhibitor, THZ1, impairs recruitment of essential HR proteins to DSBs, implicating nascent RNA in DNA end resection, initiation and execution of HR repair. We further propose that resection factor CtIP interacts with and helps re-activate RNAPII when paused by the RNA:DNA hybrids, collectively promoting faithful repair of chromosome breaks to maintain genomic integrity.
RNA has been implicated in DNA repair. This work shows that the interplay of RNAPII-generated nascent RNA, RNA:DNA hybrids and the resection factor CtIP guide DNA double strand break repair pathway choice towards error-free homologous recombination.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Pappas, George 2
; Aguilar-Morante, Diana 3
; Dinant, Christoffel 2 ; Bartek, Jiri 4
1 Danish Cancer Society Research Center, Genome Integrity Group, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024); Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922); Universidad de Sevilla, Departamento de Genética, Facultad de Biología, Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229)
2 Danish Cancer Society Research Center, Genome Integrity Group, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024)
3 Danish Cancer Society Research Center, Genome Integrity Group, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024); Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Instituto de Biomedicina de Sevilla (IBiS), Seville, Spain (GRID:grid.414816.e) (ISNI:0000 0004 1773 7922)
4 Danish Cancer Society Research Center, Genome Integrity Group, Copenhagen, Denmark (GRID:grid.417390.8) (ISNI:0000 0001 2175 6024); Science for Life Laboratory, Karolinska Institute, Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)




